首页> 外文期刊>American Journal of PharmTech Research >Floating In Situ Gelling Drug Delivery System of Verapamil Hydrochloride
【24h】

Floating In Situ Gelling Drug Delivery System of Verapamil Hydrochloride

机译:盐酸维拉帕米漂浮原位凝胶给药系统

获取原文
           

摘要

  ABSTRACT   Gastro retentive drug delivery system has been widely used to prolong retention of dosage forms in stomach. Amongst the various approaches, the Raft formulation offers sustained drug release as well as prolonged gastric retention, along with the added advantage of liquid oral dosage form. The present study was an attempt to formulate and evaluate Raft forming floating drug delivery system for Verapamil Hydrochloride which undergoes pH dependent sol-gel transition at gastric pH; thereby prolonging the retention of the system in stomach. Gellan gum (Gelrite®) was employed as gelling agent whose gelation is triggered by source of Ca2+ ions in the form of Calcium Carbonate. The evaluation was carried out for In Vitro parameters and the results substantiated that the optimized formulation revealed excellent floating characteristics and gastric retention. Keywords: Verapamil Hydrochloride, Raft, In situ gelation, gastroretentive.
机译:摘要Gastro固位递药系统已被广泛用于延长剂型在胃中的保留时间。在多种方法中,Raft制剂可提供持续的药物释放以及延长的胃滞留性,以及液体口服剂型的其他优势。本研究试图为盐酸维拉帕米配制和评估形成筏的浮动药物递送系统,该系统在胃液pH值下经历pH依赖的溶胶-凝胶转变。从而延长了系统在胃中的保留时间。结冷胶被用作胶凝剂,其胶凝作用是由碳酸钙形式的Ca2 +离子源触发的。对体外参数进行了评估,结果证实了优化的配方显示出优异的漂浮特性和胃retention留。关键字:盐酸维拉帕米,筏,原位凝胶化,胃滞留性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号